» Articles » PMID: 33294256

Application of Artificial Intelligence to the Diagnosis and Therapy of Colorectal Cancer

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2020 Dec 9
PMID 33294256
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence (AI) is a relatively new branch of computer science involving many disciplines and technologies, including robotics, speech recognition, natural language and image recognition or processing, and machine learning. Recently, AI has been widely applied in the medical field. The effective combination of AI and big data can provide convenient and efficient medical services for patients. Colorectal cancer (CRC) is a common type of gastrointestinal cancer. The early diagnosis and treatment of CRC are key factors affecting its prognosis. This review summarizes the research progress and clinical application value of AI in the investigation, early diagnosis, treatment, and prognosis of CRC, to provide a comprehensive theoretical basis for AI as a promising diagnostic and treatment tool for CRC.

Citing Articles

Circulating exosomal PCAT1 as a complement of carcinoembryonic antigen for early colorectal cancer diagnosis.

Cao J, Chao W, Zhang J, Mao J, Zeng J, Luo D Heliyon. 2024; 10(20):e39264.

PMID: 39640681 PMC: 11620264. DOI: 10.1016/j.heliyon.2024.e39264.


An interpretable machine learning system for colorectal cancer diagnosis from pathology slides.

Neto P, Montezuma D, Oliveira S, Oliveira D, Fraga J, Monteiro A NPJ Precis Oncol. 2024; 8(1):56.

PMID: 38443695 PMC: 10914836. DOI: 10.1038/s41698-024-00539-4.


Gynaecological Artificial Intelligence Diagnostics (GAID) GAID and Its Performance as a Tool for the Specialist Doctor.

Tanos P, Yiangou I, Prokopiou G, Kakas A, Tanos V Healthcare (Basel). 2024; 12(2).

PMID: 38255110 PMC: 10815463. DOI: 10.3390/healthcare12020223.


IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53.

He B, Liang J, Qin Q, Zhang Y, Shi S, Cao J Genes Dis. 2023; 11(1):495-508.

PMID: 37588218 PMC: 10425805. DOI: 10.1016/j.gendis.2023.01.027.


Editorial: Artificial intelligence in colorectal cancers.

Cianci P, Tartaglia N, Ambrosi A, Restini E Front Oncol. 2023; 13:1206311.

PMID: 37287913 PMC: 10242180. DOI: 10.3389/fonc.2023.1206311.


References
1.
Ou C, Sun Z, Li X, Li X, Ren W, Qin Z . MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Lett. 2017; 399:53-63. DOI: 10.1016/j.canlet.2017.04.011. View

2.
Oyaga-Iriarte E, Insausti A, Sayar O, Aldaz A . Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters. J Pharmacol Sci. 2019; 140(1):20-25. DOI: 10.1016/j.jphs.2019.03.004. View

3.
Gupta P, Chiang S, Sahoo P, Mohapatra S, You J, Onthoni D . Prediction of Colon Cancer Stages and Survival Period with Machine Learning Approach. Cancers (Basel). 2019; 11(12). PMC: 6966646. DOI: 10.3390/cancers11122007. View

4.
Nowak-Sliwinska P, Scapozza L, Ruiz i Altaba A . Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochim Biophys Acta Rev Cancer. 2019; 1871(2):434-454. PMC: 6528778. DOI: 10.1016/j.bbcan.2019.04.005. View

5.
Hu H, Niu Z, Bai Y, Tan X . Cancer classification based on gene expression using neural networks. Genet Mol Res. 2016; 14(4):17605-11. DOI: 10.4238/2015.December.21.33. View